Identification of a red-emitting fluorescent ligand for in vitro visualization of human serotonin 5-HT1A receptors

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 22, 2010, Pages 6628-6632

  Lacivita, Enza ^a   Masotti, Anna Carmela ^a   Jafurulla, Md ^b   Saxena, Roopali ^b   Rangaraj, Nandini ^b   Chattopadhyay, Amitabha ^b   Colabufo, Nicola A ^a   Berardi, Francesco ^a   Perrone, Roberto ^a   Leopoldo, Marcello ^a  

^a UNIVERSITY OF BARI   (Italy)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

1 Arylpiperazine; 5 HT1A receptor; Confocal laser scanning microscopy; Fluorescence; SAR

Indexed keywords

1 ARYLPIPERAZINE DERIVATIVE; PIPERAZINE DERIVATIVE; RED FLUORESCENT PROTEIN; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CHO CELL; CONFOCAL LASER MICROSCOPY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; FLUORESCENCE; IN VITRO STUDY; NONHUMAN; PHARMACOPHORE; STRUCTURE ACTIVITY RELATION;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; FLUORESCENT DYES; HUMANS; LIGANDS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; RECEPTOR, SEROTONIN, 5-HT1A;

EID: 77958043877     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.09.027     Document Type: Article

References (33)

1. T.J. Pucadyil, S. Kalipatnapu, and A. Chattopadhyay Cell. Mol. Neurobiol. 25 2005 553
2. S. Kalipatnapu, and A. Chattopadhyay Cell. Mol. Neurobiol. 27 2007 1097
3. J.R. Raymond, Y.V. Mukhin, T.W. Gettys, and M.N. Garnovskaya Br. J. Pharmacol. 127 1999 1751
4. E. Lacivita, M. Leopoldo, F. Berardi, and R. Perrone Curr. Top. Med. Chem. 8 2008 1024
5. C.J. Daly, and J.C. McGrath Pharmacol. Ther. 100 2003 101
6. S.J. Briddon, and S.J. Hill Trends Pharmacol. Sci. 28 2007 637
7. Alonso, D.; Vasquez-Villa, H.; Gamo, A. M.; Martinez-Esperon, M. F.; Tortosa, M.; Viso, A.; Fernández de la Pradilla, R.; Junquera, E.; Aicart, E.; Martin-Fontecha, M.; Benhamú, B.; López-Rodriguez, M. L.; Ortega-Gutierrez, S. ACS Med. Chem. Lett. 2010, published on line May 14, 2010. doi: 10.1021/ml100053y.
8. http://www.cellaura.com/product-details/26/index.html, last accessed on July 2010.
9. E. Lacivita, and M. Leopoldo J. Med. Chem. 51 2008 1492
10. E. Lacivita, M. Leopoldo, A.C. Masotti, C. Inglese, F. Berardi, R. Perrone, S. Ganguly, M. Jafurulla, and A. Chattopadhyay J. Med. Chem. 52 2009 7892
11. A. Koman, V.M. Kolb, and L. Terenius Pharm. Res. 3 1986 56
12. V. Korlipara, J. Ells, J. Wang, R. Tam, S. Elde, and P.S. Portoghese Eur. J. Med. Chem. 32 1997 171
13. T. Kshirsagar, A.H. Nakano, P.-Y. Law, R. Elde, and P.S. Portoghese Neurosci. Lett. 249 1998 83
14. M. Leopoldo, E. Lacivita, F. Berardi, and R. Perrone Drug Discov. Today 14 2009 706
15. J.G. Baker, R. Middleton, L. Adams, L.T. May, S.J. Briddon, B. Kellam, and S.J. Hill Br. J. Pharmacol. 159 2010 772
16. M. Leopoldo, E. Lacivita, N.A. Colabufo, M. Niso, F. Berardi, and R. Perrone Bioorg. Med. Chem. 15 2007 5316
17. J.L. Mokrosz, M.J. Mokrosz, S. Charakchieva-Minol, M.H. Paluchowska, A.J. Bojarski, and B. Duszyńska Arch. Pharm. (Weinheim) 328 1995 143
18. K. Shah, and R. Weissleder Am. Soc. Exp. NeuroTher. 2 2005 215
19. Part of this study was presented at 'XXIII National Congress of the Italian Chemical Society', July 5-10, Sorrento, Italy, 2009. Book of Abstracts, p 150, FAR-NK-5.
20. Czerney, P.; Wenzel, M.; Schweder, B.; Lehmann, F. US 2004 260093; CAN 142:76184.
21. J.-S. Wu, W.-M. Liu, X.-Q. Zhuang, F. Wang, P.-F. Wang, S.-L. Tao, X.-H. Zhang, S.-K. Wu, and S.-T. Lee Org. Lett. 9 2007 33
22. J.T.C. Wojtyk, P.M. Kazmaier, and E. Buncel Chem. Mater. 13 2001 2547
23. M. Leopoldo, F. Berardi, N.A. Colabufo, M. Contino, E. Lacivita, R. Perrone, and V. Tortorella J. Pharm. Pharmacol. 56 2004 247
24. +/MS/MS m/z 565 (100).
25. L. Strekowski, C.L. Mason, H. Lee, R. Gupta, J. Sowell, and G. Patonay J. Heterocycl. Chem. 40 2003 913
26. M.F. Moreau, F. Lapalus, and G. Meyniel Eur. J. Med. Chem. 9 1974 274
27. J.H. Flanagan Jr., S.H. Khan, S. Menchen, S.A. Soper, and R.P. Hammer Bioconjug. Chem. 8 1997 751
28. Y. Wu, K.R. Smith, J.W. Rayburn, and J.W. Kissel J. Med. Chem. 12 1969 876
29. +/MS/MS m/z 1104 (100), 555 (13).
30. A. Fargin, J.R. Raymond, J.W. Regan, S. Cotecchia, R.J. Lefkowitz, and M.G. Caron J. Biol. Chem. 264 1989 14848
31. Y.C. Cheng, and W.H. Prusoff Biochem. Pharmacol. 22 1973 3099
32. 2O (Φ = 0.90) for compound 6; ICG in DMSO (Φ = 0.013) for compound 7. Quantum yields were calculated according to: Demas, J. N.; Crosby, G. A. Phys. Chem. 1971, 75, 991. Absorption spectra were recorded with a PerkinElmer UV-vis-NIR spectrophotometer, fluorescence spectra were obtained with a PerkinElmer LS55 spectrofluorometer.
33. 2+. Cells were incubated with 2 μM of compound 6 for 5 min at 4 °C in order to inhibit endocytosis. To competitively wash off the compound 6, PBS containing 2 mM 5-HT (1000-fold excess) was used. Cells grown in Lab-Tek chambers (Nunc, Denmark) were observed with a Zeiss LSM 510 Meta NLO confocal microscope (Jena, Germany). The imaging was performed with 63×, 1.4 NA, oil immersion objective. Compound 6 was excited at 561 nm with DPSS laser, and emission was collected using a bandpass filter at 575-630 nm.